Carpenter (CRS) Q4 EPS Jumps 21%

Carpenter Technology (NYSE:CRS) reported robust Q4 FY2025 results, with non-GAAP EPS of $2.21 exceeding estimates and adjusted free cash flow surging 421.5% to $201.3 million, despite a 5.4% year-over-year GAAP revenue decline to $755.6 million. The company achieved record operating margins and profitability, driven by strategic product mix and pricing that offset volume pressures, leading to a strong financial position with a 0.5x net debt-to-EBITDA. Management projects continued growth, with FY2026 adjusted operating income forecast to rise 26-33%, underpinned by significant investment in high-purity melt capacity expansion.

Analysis

Carpenter Technology's Q4 FY2025 results present a clear case of strategic execution prioritizing profitability over volume. While GAAP revenue missed estimates, declining 5.4% year-over-year to $755.6 million, this was more than offset by a significant improvement in financial quality. The company delivered a 6.8% beat on non-GAAP EPS, which rose to $2.21, driven by a 39.8% YoY increase in operating income and a record-high adjusted operating margin of 24.3%. This margin expansion, up 4.6 percentage points, was a direct result of a richer product mix and disciplined pricing, particularly within the Specialty Alloys Operations segment, which saw margins hit 30.5% despite an 18% drop in shipment volume. The financial health of the company is exceptionally strong, highlighted by a 421.6% surge in adjusted free cash flow to $201.3 million and a historic low net debt-to-EBITDA ratio of 0.5x. Strength in the core Aerospace & Defense and Energy end-markets is currently balancing cyclical weakness in the Medical and Transportation sectors. Looking ahead, management's guidance for 26-33% growth in FY2026 adjusted operating income, supported by a $400 million capacity expansion project targeting over $150 million in incremental income by FY2030, signals strong confidence in sustained performance.

Key Decisions for Investors

• Investors should look past the headline revenue miss and focus on the company's record-setting profitability, evidenced by the 4.6 percentage point expansion in adjusted operating margin and the 421.6% surge in adjusted free cash flow.
• The strong FY2026 guidance, projecting 26-33% growth in adjusted operating income, combined with the strategic $400 million capacity expansion, presents a compelling long-term growth narrative.
• Monitor for a potential recovery in the Medical and Transportation end-markets, as a turnaround would provide an additional growth catalyst, while continued softness in these areas remains a key risk to overall shipment volumes.
• The robust balance sheet, with a net debt-to-EBITDA ratio of just 0.5x, de-risks the investment profile and provides strong support for the company's dividend and share repurchase programs.